47 related articles for article (PubMed ID: 16799172)
1. Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial.
Flicoteaux R; Protopopescu C; Tibi A; Blanchon T; Werf SV; Duval X; Mosnier A; Charlois-Ou C; Lina B; Leport C; Chevret S
BMJ Open; 2017 Jul; 7(7):e014546. PubMed ID: 28698321
[TBL] [Abstract][Full Text] [Related]
2. Side effects of oseltamivir in end-stage renal failure patients.
Choo D; Hossain M; Liew P; Chowdhury S; Tan J
Nephrol Dial Transplant; 2011 Jul; 26(7):2339-44. PubMed ID: 21193643
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis.
Patel K; Rayner CR; Giraudon M; Kamal MA; Morcos PN; Robson R; Kirkpatrick CM
Br J Clin Pharmacol; 2015 Apr; 79(4):624-35. PubMed ID: 25289522
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations.
Davies BE
J Antimicrob Chemother; 2010 Apr; 65 Suppl 2(Suppl 2):ii5-ii10. PubMed ID: 20215135
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin dosing based on ideal body weight versus actual body weight: comparison of clinical outcomes.
Ng JK; Schulz LT; Rose WE; Fox BC; Andes DR; Buhr KA; Fish JT
Antimicrob Agents Chemother; 2014; 58(1):88-93. PubMed ID: 24145531
[TBL] [Abstract][Full Text] [Related]
6. A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections.
Lee N; Hui DS; Zuo Z; Ngai KL; Lui GC; Wo SK; Tam WW; Chan MC; Wong BC; Wong RY; Choi KW; Sin WW; Lee EL; Tomlinson B; Hayden FG; Chan PK
Clin Infect Dis; 2013 Dec; 57(11):1511-9. PubMed ID: 24046309
[TBL] [Abstract][Full Text] [Related]
7. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis.
Hansrivijit P; Qian C; Boonpheng B; Thongprayoon C; Vallabhajosyula S; Cheungpasitporn W; Ghahramani N
J Investig Med; 2020 Oct; 68(7):1261-1270. PubMed ID: 32655013
[TBL] [Abstract][Full Text] [Related]
8. Novel Influenza A (H1N1/09) Virus Infection during Pregnancy in a Kidney Transplant Recipient.
Rothermund L; Kreutz R; Keller F
Case Rep Nephrol; 2011; 2011():636030. PubMed ID: 24533193
[TBL] [Abstract][Full Text] [Related]
9. High levels and safety of oseltamivir carboxylate plasma concentrations after nasogastric administration in critically ill children in a pediatric intensive care unit.
Giraud C; Manceau S; Oualha M; Chappuy H; Mogenet A; Duchêne P; Ducrocq S; Hubert P; Treluyer JM
Antimicrob Agents Chemother; 2011 Jan; 55(1):433-5. PubMed ID: 20937783
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
Widmer N; Meylan P; Ivanyuk A; Aouri M; Decosterd LA; Buclin T
Clin Pharmacokinet; 2010 Nov; 49(11):741-65. PubMed ID: 20923248
[TBL] [Abstract][Full Text] [Related]
11. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy and prophylaxis for influenza in children.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
[TBL] [Abstract][Full Text] [Related]
13. Antiviral drugs for seasonal influenza 2014-2015.
Med Lett Drugs Ther; 2014; 56(1457):121-3. PubMed ID: 25423066
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure.
Karie S; Launay-Vacher V; Janus N; Izzedine H; Deray G
Nephrol Dial Transplant; 2006 Dec; 21(12):3606-8. PubMed ID: 16799172
[No Abstract] [Full Text] [Related]
15. Antiviral drugs for influenza.
Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
[No Abstract] [Full Text] [Related]
16. [Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?].
Rosenborg S
Lakartidningen; 2010 Jan 20-26; 107(3):116-7. PubMed ID: 20225688
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
